Monocyte-derived dendritic cells: Targets as potent antigen-presenting cells for the design of vaccines against infectious diseases

International Journal of Infectious Diseases

Volumn 19, Issue 1, 2014, Pages 1-5

  Qu, Chunfeng ^a   Brinck Jensen, Nanna Sophie ^b   Zang, Mengya ^a   Chen, Kun ^a  

^a CANCER HOSPITAL   (China)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Infectious diseases; Monocyte derived dendritic cells; Monocytes; Vaccine design

Indexed keywords

VACCINE;

CELL DIFFERENTIATION; CELL FUNCTION; CELL HETEROGENEITY; CYTOLOGY; DENDRITIC CELL; HUMAN; INFECTION; INFLAMMATION; MACROPHAGE; MONOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; REVIEW; STEADY STATE; STEM CELL; ANTIGEN PRESENTATION; DRUG DESIGN; MONOCYTE DERIVED DENDRITIC CELL; TARGET CELL; ANIMAL; ANTIGEN PRESENTING CELL; CHRONIC DISEASE; COMMUNICABLE DISEASE; IMMUNOLOGY; INFECTION CONTROL; MOUSE;

ANIMALS; ANTIGEN-PRESENTING CELLS; CELL DIFFERENTIATION; CHRONIC DISEASE; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; DENDRITIC CELLS; HUMANS; INFLAMMATION; MICE; MONOCYTES; PHENOTYPE; VACCINES;

EID: 84892875254     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2013.09.023     Document Type: Review

References (77)

1. Randolph G.J., Jakubzick C., Qu C. Antigen presentation by monocytes and monocyte-derived cells. Curr Opin Immunol 2008, 20:52-60.
2. Auffray C., Sieweke M.H., Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 2009, 27:669-692.
3. Ziegler-Heitbrock L., Ancuta P., Crowe S., Dalod M., Grau V., Hart D.N., et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010, 116:e74-e80.
4. Geissmann F., Gordon S., Hume D.A., Mowat A.M., Randolph G.J. Unravelling mononuclear phagocyte heterogeneity. Nat Rev Immunol 2010, 10:453-460.
5. Belz G.T., Nutt S.L. Transcriptional programming of the dendritic cell network. Nat Rev Immunol 2012, 12:101-113.
6. Passlick B., Flieger D., Ziegler-Heitbrock H.W. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 1989, 74:2527-2534.
7. Sanchez-Torres C., Garcia-Romo G.S., Cornejo-Cortes M.A., Rivas-Carvalho A., Sanchez-Schmitz G. CD16+ and CD16- human blood monocyte subsets differentiate in vitro to dendritic cells with different abilities to stimulate CD4+ T cells. Int Immunol 2001, 13:1571-1581.
8. Randolph G.J., Sanchez-Schmitz G., Liebman R.M., Schakel K. The CD16(+) (FcgammaRIII(+)) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting. J Exp Med 2002, 196:517-527.
9. Ancuta P., Rao R., Moses A., Mehle A., Shaw S.K., Luscinskas F.W., et al. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J Exp Med 2003, 197:1701-1707.
10. Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 2007, 81:584-592.
11. Mizuno K., Toma T., Tsukiji H., Okamoto H., Yamazaki H., Ohta K., et al. Selective expansion of CD16highCCR2-subpopulation of circulating monocytes with preferential production of haem oxygenase (HO)-1 in response to acute inflammation. Clin Exp Immunol 2005, 142:461-470.
12. Horelt A., Belge K.U., Steppich B., Prinz J., Ziegler-Heitbrock L. The CD14+CD16+ monocytes in erysipelas are expanded and show reduced cytokine production. Eur J Immunol 2002, 32:1319-1327.
13. Cairns A.P., Crockard A.D., Bell A.L. The CD14+ CD16+ monocyte subset in rheumatoid arthritis and systemic lupus erythematosus. Rheumatol Int 2002, 21:189-192.
14. Rossol M., Kraus S., Pierer M., Baerwald C., Wagner U. The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population. Arthritis Rheum 2012, 64:671-677.
15. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994, 179:1109-1118.
16. Romani N., Gruner S., Brang D., Kampgen E., Lenz A., Trockenbacher B., et al. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994, 180:83-93.
17. Randolph G.J., Luther T., Albrecht S., Magdolen V., Muller W.A. Role of tissue factor in adhesion of mononuclear phagocytes to and trafficking through endothelium in vitro. Blood 1998, 92:4167-4177.
18. Hume D.A. The mononuclear phagocyte system. Curr Opin Immunol 2006, 18:49-53.
19. Qu C., Edwards E.W., Tacke F., Angeli V., Llodra J., Sanchez-Schmitz G., et al. Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes. J Exp Med 2004, 200:1231-1241.
20. Geissmann F., Jung S., Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19:71-82.
21. Tacke F., Randolph G.J. Migratory fate and differentiation of blood monocyte subsets. Immunobiology 2006, 211:609-618.
22. Ingersoll M.A., Spanbroek R., Lottaz C., Gautier E.L., Frankenberger M., Hoffmann R., et al. Comparison of gene expression profiles between human and mouse monocyte subsets. Blood 2010, 115:e10-e19.
23. Sunderkotter C., Nikolic T., Dillon M.J., Van Rooijen N., Stehling M., Drevets D.A., et al. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol 2004, 172:4410-4417.
24. Nikolic T., de Bruijn M.F., Lutz M.B., Leenen P.J. Developmental stages of myeloid dendritic cells in mouse bone marrow. Int Immunol 2003, 15:515-524.
25. Villadangos J.A., Schnorrer P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat Rev Immunol 2007, 7:543-555.
26. Cisse B., Caton M.L., Lehner M., Maeda T., Scheu S., Locksley R., et al. Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 2008, 135:37-48.
27. Ghosh H.S., Cisse B., Bunin A., Lewis K.L., Reizis B. Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells. Immunity 2010, 33:905-916.
28. Onai N., Kurabayashi K., Hosoi-Amaike M., Toyama-Sorimachi N., Matsushima K., Inaba K., et al. A clonogenic progenitor with prominent plasmacytoid dendritic cell developmental potential. Immunity 2013, 38:943-957.
29. Fogg D.K., Sibon C., Miled C., Jung S., Aucouturier P., Littman D.R., et al. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 2006, 311:83-87.
30. Onai N., Obata-Onai A., Schmid M.A., Ohteki T., Jarrossay D., Manz M.G. Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow. Nat Immunol 2007, 8:1207-1216.
31. Villadangos J.A., Heath W.R. Life cycle, migration and antigen presenting functions of spleen and lymph node dendritic cells: limitations of the Langerhans cells paradigm. Semin Immunol 2005, 17:262-272.
32. Kabashima K., Banks T.A., Ansel K.M., Lu T.T., Ware C.F., Cyster J.G. Intrinsic lymphotoxin-beta receptor requirement for homeostasis of lymphoid tissue dendritic cells. Immunity 2005, 22:439-450.
33. Naik S.H., Metcalf D., van Nieuwenhuijze A., Wicks I., Wu L., O'Keeffe M., et al. Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat Immunol 2006, 7:663-671.
34. Liu K., Waskow C., Liu X., Yao K., Hoh J., Nussenzweig M. Origin of dendritic cells in peripheral lymphoid organs of mice. Nat Immunol 2007, 8:578-583.
35. Liu K., Victora G.D., Schwickert T.A., Guermonprez P., Meredith M.M., Yao K., et al. In vivo analysis of dendritic cell development and homeostasis. Science 2009, 324:392-397.
36. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991, 9:271-296.
37. Naik S.H., Sathe P., Park H.Y., Metcalf D., Proietto A.I., Dakic A., et al. Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nat Immunol 2007, 8:1217-1226.
38. D'Amico A., Wu L. The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3. J Exp Med 2003, 198:293-303.
39. Randolph G.J., Ochando J., Partida-Sanchez S. Migration of dendritic cell subsets and their precursors. Annu Rev Immunol 2008, 26:293-316.
40. Heard J.M., Roussel M.F., Rettenmier C.W., Sherr C.J. Multilineage hematopoietic disorders induced by transplantation of bone marrow cells expressing the v-fms oncogene. Cell 1987, 51:663-673.
41. Jakubzick C., Bogunovic M., Bonito A.J., Kuan E.L., Merad M., Randolph G.J. Lymph-migrating, tissue-derived dendritic cells are minor constituents within steady-state lymph nodes. J Exp Med 2008, 205:2839-2850.
42. Dhodapkar M.V., Steinman R.M., Sapp M., Desai H., Fossella C., Krasovsky J., et al. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. J Clin Invest 1999, 104:173-180.
43. Thurner B., Haendle I., Roder C., Dieckmann D., Keikavoussi P., Jonuleit H., et al. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med 1999, 190:1669-1678.
44. Schuler-Thurner B., Dieckmann D., Keikavoussi P., Bender A., Maczek C., Jonuleit H., et al. Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells. J Immunol 2000, 165:3492-3496.
45. Shortman K., Naik S.H. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 2007, 7:19-30.
46. Randolph G.J., Inaba K., Robbiani D.F., Steinman R.M., Muller W.A. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 1999, 11:753-761.
47. Randolph G.J., Beaulieu S., Lebecque S., Steinman R.M., Muller W.A. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 1998, 282:480-483.
48. Ginhoux F., Tacke F., Angeli V., Bogunovic M., Loubeau M., Dai X.M., et al. Langerhans cells arise from monocytes in vivo. Nat Immunol 2006, 7:265-273.
49. Varol C., Landsman L., Fogg D.K., Greenshtein L., Gildor B., Margalit R., et al. Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J Exp Med 2007, 204:171-180.
50. Jakubzick C., Tacke F., Ginhoux F., Wagers A.J., van Rooijen N., Mack M., et al. Blood monocyte subsets differentially give rise to CD103+ and CD103- pulmonary dendritic cell populations. J Immunol 2008, 180:3019-3027.
51. Carotta S., Dakic A., D'Amico A., Pang S.H., Greig K.T., Nutt S.L., et al. The transcription factor PU.1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner. Immunity 2010, 32:628-641.
52. Merad M., Sathe P., Helft J., Miller J., Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 2013, 31:563-604.
53. Bakri Y., Sarrazin S., Mayer U.P., Tillmanns S., Nerlov C., Boned A., et al. Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate. Blood 2005, 105:2707-2716.
54. Karsunky H., Merad M., Cozzio A., Weissman I.L., Manz M.G. Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo. J Exp Med 2003, 198:305-313.
55. Pixley F.J., Stanley E.R. CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol 2004, 14:628-638.
56. Lin H., Lee E., Hestir K., Leo C., Huang M., Bosch E., et al. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 2008, 320:807-811.
57. Wang Y., Szretter K.J., Vermi W., Gilfillan S., Rossini C., Cella M., et al. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat Immunol 2012, 13:753-760.
58. Kawai T., Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34:637-650.
59. Leon B., Ardavin C. Monocyte-derived dendritic cells in innate and adaptive immunity. Immunol Cell Biol 2008, 86:320-324.
60. Gerard C., Rollins B.J. Chemokines and disease. Nat Immunol 2001, 2:108-115.
61. Charo I.F., Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006, 354:610-621.
62. Charo I.F., Myers S.J., Herman A., Franci C., Connolly A.J., Coughlin S.R. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc Natl Acad Sci U S A 1994, 91:2752-2756.
63. Boring L., Gosling J., Chensue S.W., Kunkel S.L., Farese R.V., Broxmeyer H.E., et al. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 1997, 100:2552-2561.
64. Leon B., Lopez-Bravo M., Ardavin C. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 2007, 26:519-531.
65. Zhao X., Deak E., Soderberg K., Linehan M., Spezzano D., Zhu J., et al. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med 2003, 197:153-162.
66. Allan R.S., Waithman J., Bedoui S., Jones C.M., Villadangos J.A., Zhan Y., et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 2006, 25:153-162.
67. Le Borgne M., Etchart N., Goubier A., Lira S.A., Sirard J.C., van Rooijen N., et al. Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo. Immunity 2006, 24:191-201.
68. Qu C., Nguyen V., Merad M., Randolph G. MHC class I/peptide transfer between dendritic cells overcomes poor cross-presentation by monocyte-derived APCs that engulf dying cells. J Immunol 2009, 182:3650-3659.
69. Cheong C., Matos I., Choi J.H., Dandamudi D.B., Shrestha E., Longhi M.P., et al. Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell 2010, 143:416-429.
70. Qu C., Moran T.M., Randolph G.J. Autocrine type I IFN and contact with endothelium promote the presentation of influenza A virus by monocyte-derived APC. J Immunol 2003, 170:1010-1018.
71. Iijima N., Mattei L.M., Iwasaki A. Recruited inflammatory monocytes stimulate antiviral Th1 immunity in infected tissue. Proc Natl Acad Sci U S A 2011, 108:284-289.
72. Chatterjee B., Smed-Sorensen A., Cohn L., Chalouni C., Vandlen R., Lee B.C., et al. Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells. Blood 2012, 120:2011-2020.
73. Cohn L., Chatterjee B., Esselborn F., Smed-Sorensen A., Nakamura N., Chalouni C., et al. Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation. J Exp Med 2013, 210:1049-1063.
74. Amanna I.J., Slifka M.K. Contributions of humoral and cellular immunity to vaccine-induced protection in humans. Virology 2011, 411:206-215.
75. Steinman R.M. Dendritic cells in vivo: a key target for a new vaccine science. Immunity 2008, 29:319-324.
76. van Duin D., Medzhitov R., Shaw A.C. Triggering TLR signaling in vaccination. Trends Immunol 2006, 27:49-55.
77. Du J., Wu Z., Ren S., Wei Y., Gao M., Randolph G.J., et al. TLR8 agonists stimulate newly recruited monocyte-derived cells into potent APCs that enhance HBsAg immunogenicity. Vaccine 2010, 28:6273-6281.